Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neuralgia × Morphine × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 19 Pain 16 Cancer Pain 15 Pain, Postoperative 9 Chronic Pain 7 Agnosia 5 Colonic Neoplasms 4 Breast Neoplasms 4 Multiple Myeloma 3 Mucositis 3 Lymphoma 3 Lung Neoplasms 3 Leukemia, Myeloid, Acute 3 Leukemia, Biphenotypic, Acute 3 Leukemia 3 Wounds and Injuries 2 Waldenstrom Macroglobulinemia 2 Thrombocythemia, Essential 2 Supratentorial Neoplasms 2 Sezary Syndrome 2 Primary Myelofibrosis 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Precancerous Conditions 2 Polycythemia Vera 2 Pdgfra-Associated Chronic Eosinophilic Leukemia 2 Pancreatic Neoplasms 2 Pain, Intractable 2 Neoplastic Cells, Circulating 2 Neoplasms, Plasma Cell 2

Interventions

Pregabalin 4 Lidocaine 4 Surveys and Questionnaires 3 Bupivacaine 3 ziconotide 2 Transcranial Magnetic Stimulation 2 Oxycodone 2 onabotulinum toxin A 1 nabiximols 1 Yoga 1 Vitamin B 6 1 Vitamin B 12 1 Vinorelbine 1 Vincristine 1 Thalidomide 1 Telmisartan 1 Tapentadol 1 Sodium Chloride 1 Saline Solution 1 Plastic Surgery Procedures 1 Paclitaxel 1 Oxaliplatin 1 Morphine 1 Methadone 1 Low-Level Light Therapy 1 Lidoderm 1 Ketamine 1 KRN 5500 1 Hydromorphone 1 Hospitals 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01946555 2016-04-14

RER

Mario Negri Institute for Pharmacological Research

Cancer Pain, Neoplasms, Neuralgia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡